2C
MSOS icon

272 Capital’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

272 Capital’s Portfolio MSOS Stock Details MSOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-37,791
Closed -$277K – 73
2024
Q2 		$277K Buy
+37,791
New +$330K 0.14% 57

Other funds holding MSOS

CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

272 Capital's MSOS Position: Q3 2024 in Review

272 Capital sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q3 2024, closing a stake of 37,791 shares — an estimated $277K sold.

272 Capital first reported a position in MSOS in Q2 2024 and held it in 1 quarter. The position peaked at $277K in Q2 2024. 170 funds tracked by Wall St. Rank hold MSOS as of Q3 2024.

  • 272 Capital reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q3 2024 after selling out during the quarter.
  • 272 Capital sold 37,791 AdvisorShares Pure US Cannabis ETF shares in Q3 2024, an estimated $277K.
  • 272 Capital first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2024 and held it in 1 quarter.
  • 272 Capital's AdvisorShares Pure US Cannabis ETF position peaked at $277K in Q2 2024.
  • 170 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q3 2024.

Based on 272 Capital's 13F filing for Q3 2024, filed 14 Nov 2024.